• Isoproterenol Sulfate Dihydrate: Driving Human Cardiac Assem

  2026-06-15

  Isoproterenol sulfate dihydrate delivers robust, reproducible beta-adrenergic signaling control for modeling human cardiac pacemaker maturation and neuro-cardiac interactions. This guide details optimized experimental workflows, key innovations from recent assembloid research, and actionable troubleshooting for advanced cardiovascular studies.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Precision in Apo

  2026-06-15

  The One-step TUNEL Cy5 Apoptosis Detection Kit delivers Cy5-powered, high-sensitivity apoptosis detection for both tissue and cell samples. Its streamlined protocol, robust multiplexing, and compatibility with fluorescence microscopy and flow cytometry make it a cornerstone for programmed cell death research and experimental optimization.

• (R,S)-Anatabine in Alzheimer's Research: Beyond Amyloid Redu

  2026-06-14

  (R,S)-Anatabine emerges as a powerful Alzheimer's disease research compound, uniquely combining amyloid-beta inhibition and inflammatory pathway modulation. This article provides a deep, mechanistic perspective and explores advanced assay design strategies not covered elsewhere.

• Targeting SPP1 in Tumor Myeloid Cells Reduces Tumor Burden

  2026-06-13

  The reference study introduces a phenotypic screening platform to identify and deliver small molecule SPP1 modulators specifically to tumor-associated macrophages (TAMs), resulting in significant tumor reduction in murine models. This strategy highlights the therapeutic potential of precisely reprogramming the tumor microenvironment by targeting key myeloid-derived pro-tumorigenic factors.

• Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV

  2026-06-12

  This study redefines the pharmacological boundaries of P-, Q-, and N-type calcium channels by characterizing the low-affinity inhibition of neuronal N-type Ca channels by spider toxin v-Agatoxin-IVA. The findings clarify toxin selectivity and provide new insights into the complexity of calcium channel classification in mammalian neurons.

• Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Technical Gu

  2026-06-12

  The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) preserves protein phosphorylation during sample preparation by inhibiting a broad spectrum of serine/threonine and tyrosine phosphatases. It is essential for workflows where accurate phospho-protein analysis is required, such as immunoblotting and kinase activity assays. This reagent is not intended for diagnostic or clinical use and should be integrated with attention to protocol boundaries.

• 1-Phenyl-2-Pentanol from Moringa Inhibits Hepatic Stellate C

  2026-06-11

  This study identifies 1-phenyl-2-pentanol (1-PHE) from Moringa oleifera as a bioactive agent that suppresses hepatic stellate cell activation, a key driver of liver fibrosis. Through in vitro and proteomic analysis, 1-PHE was shown to disrupt TGF-β1 and Wnt/β-catenin signaling, suggesting a new molecular avenue for anti-fibrotic research.

• Rifampin in Mechanistic Microbiology: Beyond Inhibition to I

  2026-06-11

  Explore how Rifampin, a potent rifamycin antibiotic, enables mechanistic microbiology by revealing new layers of bacterial resistance and transcriptional control. This article provides an in-depth, research-driven perspective on using Rifampin for advanced bacterial pathway studies.

• Balsalazide Disodium: Colonic-Targeted 5-ASA Prodrug in UC T

  2026-06-10

  Wiggins and Rajapakse's systematic review highlights balsalazide disodium as a colonic-targeted prodrug, offering faster and more effective remission in mild-to-moderate ulcerative colitis (UC) compared to mesalazine. The findings inform protocol optimization in both clinical management and preclinical IBD modeling.

• SP1/ADAM10/DRP1 Axis Regulates Cell Crosstalk in Hypoxia Pul

  2026-06-10

  This study reveals how the SP1/ADAM10/DRP1 signaling axis mediates intercellular communication between endothelial and smooth muscle cells under hypoxic conditions, driving the progression of hypoxia pulmonary hypertension (HPH). The findings identify ADAM10 as a critical regulator of SMC proliferation and apoptosis via DRP1-dependent mitochondrial dynamics, suggesting new therapeutic targets for HPH.

• Batimastat (BB-94) Unlocks Advanced MMP Inhibition Workflows

  2026-06-09

  Batimastat (BB-94) empowers researchers to precisely modulate matrix metalloproteinase activity in both cancer and neuromuscular synapse models. This article delivers actionable protocol enhancements, troubleshooting strategies, and a translation of cutting-edge mechanistic insights to help you maximize experimental reproducibility and interpretability.

• Vernakalant Hydrochloride: Mechanism, Evidence, and Vision i

  2026-06-09

  This article unpacks the mechanistic rationale, translational strategy, and evolving evidence for Vernakalant Hydrochloride (RSD1235) as an atrial-selective antiarrhythmic. Going beyond standard product summaries, it connects preclinical selectivity, protocol guidance, and clinical outcomes for rapid atrial fibrillation (AF) conversion. Strategic insights for researchers illuminate how this agent disrupts the status quo in AF modeling, with a forward-looking view on its position in the competitive landscape.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Benchmarks & Protoc

  2026-06-08

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables high-sensitivity detection of rabbit primary antibodies in immunofluorescence, immunohistochemistry, and flow cytometry. Its Cy3 conjugation amplifies signal with low background, providing reproducible results in research workflows. This article details mechanism, validated applications, and critical usage parameters.

• Bufuralol (hydrochloride) for Robust β-Adrenergic Modulation

  2026-06-08

  This article delivers practical, evidence-based guidance for deploying Bufuralol (hydrochloride) (SKU C5043) in cardiovascular pharmacology and advanced cell-based assays. Drawing on real lab scenarios, it demonstrates how this non-selective β-adrenergic receptor antagonist enhances reproducibility and data quality, especially for hiPSC-derived organoid workflows. Learn when and why APExBIO's formulation outperforms alternatives.

• Carvedilol in β-Adrenergic Receptor Research: Applied Protoc

  2026-06-07

  Carvedilol stands out in β-adrenergic receptor research due to its dual action on β- and α1-receptors, robust antioxidant properties, and unique impact on hematopoietic regeneration. This guide translates recent breakthroughs and practical lab workflows into actionable steps for cardiovascular, vascular injury, and post-transplantation studies.

14819 records 1/988 page Next 12345 下5页 Last page